Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

5 Key Elements of Successful Zika Vaccine Development

Avoid complex clinical challenges in Zika vaccine development with insights from our latest insight brief

As the global race to find cures for infectious diseases gains momentum, it’s crucial that vaccine developers and clinical laboratories work closely together to provide effective treatments to the patients that need them most.

ZikaIn this complimentary insight brief, you’ll learn about the current landscape of one of the most threatening infectious diseases, as well as 5 key elements of successful Zika vaccine development you should be using now.

Contact us today to learn more about how we use our deep scientific expertise and global laboratory footprint to partner with vaccine developers to overcome some of today’s most complex infectious disease vaccine development challenges.

About the authors:
Wayne R. Hogrefe, Ph.D., D (ABMLI), Vice President, Vaccine unit
Paul Rhyne, Ph.D., Scientific Director, Bioanalytical and ADME Immunoassay Services
Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Q2 Solutions Anti-infective and Vaccine Development Services

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Combating Emerging and Re-Emerging Infectious Diseases in Clinical Trials by Harnessing Innovative Technologies

Read More